These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2246701)

  • 1. Role of furosemide therapy after booster-packed erythrocyte transfusions in infants with bronchopulmonary dysplasia.
    Stefano JL; Bhutani VK
    J Pediatr; 1990 Dec; 117(6):965-8. PubMed ID: 2246701
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
    Prabhu VG
    Pediatrics; 1997 Sep; 100(3 Pt 1):420-1. PubMed ID: 9304111
    [No Abstract]   [Full Text] [Related]  

  • 3. Nebulized furosemide in infants with bronchopulmonary dysplasia.
    Rastogi A; Luayon M; Ajayi OA; Pildes RS
    J Pediatr; 1994 Dec; 125(6 Pt 1):976-9. PubMed ID: 7996373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia.
    Rush MG; Engelhardt B; Parker RA; Hazinski TA
    J Pediatr; 1990 Jul; 117(1 Pt 1):112-8. PubMed ID: 2196353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia.
    Kao LC; Warburton D; Sargent CW; Platzker AC; Keens TG
    J Pediatr; 1983 Oct; 103(4):624-9. PubMed ID: 6620024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia.
    Engelhardt B; Elliott S; Hazinski TA
    J Pediatr; 1986 Dec; 109(6):1034-9. PubMed ID: 3537245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
    Kugelman A; Durand M; Garg M
    Pediatrics; 1997 Jan; 99(1):71-5. PubMed ID: 8989341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilators and diuretics in children with bronchopulmonary dysplasia.
    Logvinoff MM; Lemen RJ; Taussig LM; Lamont BA
    Pediatr Pulmonol; 1985; 1(4):198-203. PubMed ID: 3840882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia.
    Kao LC; Durand DJ; McCrea RC; Birch M; Powers RJ; Nickerson BG
    J Pediatr; 1994 May; 124(5 Pt 1):772-81. PubMed ID: 8176568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants.
    LaForce WR; Brudno DS
    J Pediatr; 1993 Feb; 122(2):285-8. PubMed ID: 8429447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasia.
    Davis JM; Bhutani VK; Stefano JL; Fox WW; Spitzer AR
    Pediatr Pulmonol; 1989; 6(1):49-52. PubMed ID: 2704583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of booster blood transfusions on oxygen utilization in infants with bronchopulmonary dysplasia.
    Alverson DC; Isken VH; Cohen RS
    J Pediatr; 1988 Oct; 113(4):722-6. PubMed ID: 3171797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary and renal responses to furosemide in infants with stage III-IV bronchopulmonary dysplasia.
    Patel H; Yeh TF; Jain R; Pildes R
    Am J Dis Child; 1985 Sep; 139(9):917-9. PubMed ID: 4036927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frusemide and acute pulmonary oedema.
    Hughes JM
    Lancet; 1971 Jun; 1(7712):1297-8. PubMed ID: 4104748
    [No Abstract]   [Full Text] [Related]  

  • 15. Aerosolized furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia in preterm neonates.
    Pai VB; Nahata MC
    Ann Pharmacother; 2000 Mar; 34(3):386-92. PubMed ID: 10917388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of furosemide on body water compartments in infants with bronchopulmonary dysplasia.
    O'Donovan BH; Bell EF
    Pediatr Res; 1989 Aug; 26(2):121-4. PubMed ID: 2771518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 6-hour infusion versus bolus furosemide in premature infants.
    Reiter PD; Makhlouf R; Stiles AD
    Pharmacotherapy; 1998; 18(1):63-8. PubMed ID: 9469683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function changes after nebulised and intravenous frusemide in ventilated premature infants.
    Prabhu VG; Keszler M; Dhanireddy R
    Arch Dis Child Fetal Neonatal Ed; 1997 Jul; 77(1):F32-5. PubMed ID: 9279180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can furosemide prevent transfusion-associated circulatory overload? Results of a pilot, double-blind, randomized controlled trial.
    Pendergrast J; Armali C; Cserti-Gazdewich C; Hansen M; Kiss A; Lieberman L; Parmar N; Scales D; Skeate R; Callum J; Lin Y
    Transfusion; 2019 Jun; 59(6):1997-2006. PubMed ID: 30924166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory response and pharmacokinetics of intravenous salbutamol in infants with bronchopulmonary dysplasia.
    Kirpalani H; Koren G; Schmidt B; Tan Y; Santos R; Soldin S
    Crit Care Med; 1990 Dec; 18(12):1374-7. PubMed ID: 2173991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.